Aberrant methylation of p16 INK4a is an early event in lung cancer and a potential biomarker for early diagnosis (Q36324689)
scientific article published on September 29, 1998
Language:
(P31) (Q13442814)
(P50) (Q96685352)
(Q106304220)
(P304) 11891-11896
(P407) (Q1860)
(P433) 20
(P478) 95
(P577) Tuesday, September 1, 1998
Tuesday, September 29, 1998
(P921) (Q864574)
(Q47912)
(Q5009957)
(Q66205818)
(P953) http://www.pnas.org/content/95/20/11891.full.pdf
https://europepmc.org/articles/PMC21736
https://europepmc.org/articles/PMC21736?pdf=render
https://pnas.org/doi/pdf/10.1073/pnas.95.20.11891
(P1104) 6
(P1433) (Q1146531)
(P1476) "Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis" (language: en)
"Aberrant methylation of p16 INK4a is an early event in lung cancer and a potential biomarker for early diagnosis" (language: en)
(P2093) W. A. Palmisano
R. Michels
G. Saccomanno
E. Gabrielson
S. B. Baylin
J. G. Herman
(P2860) (Q37541079)
(Q40021115)
(Q23923034)
(Q24631957)
(Q28251933)
(Q38481941)
(Q41373289)
(Q51013454)
(Q41669364)
(Q53719094)
(Q41730727)
(Q54695279)
(Q55480673)
(Q52520672)
(Q73058204)
(Q71231236)
(Q72744200)
(Q63641308)
(Q73443322)
(Q71862654)
(Q73119785)
(Q79338024)
other details
description scientific article published on September 29, 1998

External Links